JPRN-UMIN000018855已完成未知
Prevention of hepatocarcinogenesis after combinatoin therapy with daclatasvir and asunaprevir : A pilot study in usefulness of a small amount of Peg-interferon - Prevention of hepatocarcinogenesis after combinatoin therapy with daclatasvir and asunaprevir
Department of Gastroenterology & Hepatology, Saitama Medical University0 个研究点目标入组 10 人开始时间: 2015年10月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •patients with HCC
研究者
相似试验
已完成
不适用
Prevention of hepatocellular carcinoma in patients with chronic hepatitis C and cirrhosis by pegylated IFN-alpha-2a after surgical resection or radiofrequency ablatiochronic hepatitis C,cirrhosis,hepatocellular carcinomaJPRN-C000000203Gunma Liver Study Group100
招募中
3 期
Preventive effect on recurrence of hepatocellular carcinoma by branched chain amino acids after curative hepatectomyhepatocellular carcinomaJPRN-UMIN000003363Dokkyo Medical University140
招募中
不适用
Risk of Hepatocellular Carcinoma or Decompensated Liver Cirrhosis in Patients with Chronic Liver Injury via Shear wave with Smart maps (HCC DLC-SwSm Trial)Patients with chronic liver injury or liver cirrhosisJPRN-UMIN000017323Hiroshima City Hospital1,000
招募中
不适用
Risk of Hepatocellular Carcinoma or Decompensated Liver Cirrhosis in Patients with Chronic Liver Injury via Virtual Touch Tissue QuantificatioJPRN-UMIN000004363Department Gastroenterology,Kurashiki Central Hospital1,000
进行中（未招募）
1 期
Preventing liver recurrence after partial hepatectomy for intrahepatic cholangiocarcinoma using adjuvant hepatic arterial infusion pump chemotherapy – PUMP IV trialIntrahepatic cholangiocarcinoma (iCCA)CTIS2024-513726-33-00Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)40